Liquidia Corp
LQDA
96 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 8:30 PM | Stephen M BlochDirector | Sale | 318,893 | $50.23 | $16.0M | 1,870,042(I) | View → |
| May 12, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $54.04 | $1.4M | 1,273,095(I) | View → |
| May 11, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $41.50 | $1.0M | 1,298,095(I) | View → |
| May 8, 2026 | May 12 10:52 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $42.14 | $1.1M | 1,323,095(I) | View → |
| May 11, 2026 | May 11 9:52 PM | Canaan VIII LP | Proposed Sale | 318,893 | $49.86 | $15.9M | — | View → |
| May 8, 2026 | May 8 8:19 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 100,000 | $42.28 | $4.2M | — | View → |
| May 7, 2026 | May 7 10:19 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $42.09 | $1.1M | 1,348,095(I) | View → |
| May 6, 2026 | May 7 10:19 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.78 | $1.0M | 1,373,095(I) | View → |
| May 5, 2026 | May 7 10:19 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.10 | $1.0M | 1,398,095(I) | View → |
| May 7, 2026 | May 7 8:18 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $42.14 | $1.1M | — | View → |
| Apr 27, 2026 | Apr 29 8:31 PM | Dana BoyleChief Accounting Officer | Sale | 1,576 | $37.78 | $59.5K | 175,342(D) | View → |
| Apr 27, 2026 | Apr 29 8:30 PM | Jason AdairChief Business Officer | Sale | 688 | $41.65 | $28.7K | 214,738(D) | View → |
| Apr 17, 2026 | Apr 21 8:30 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 18,839 | $40.60 | $765.0K | 1,423,095(I) | View → |
| Apr 17, 2026 | Apr 17 8:39 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 68,839 | $41.40 | $2.8M | — | View → |
| Apr 16, 2026 | Apr 17 12:38 AM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.31 | $1.0M | 1,441,934(I) | View → |
| Apr 15, 2026 | Apr 17 12:38 AM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.14 | $1.0M | 1,466,934(I) | View → |
| Apr 14, 2026 | Apr 17 12:38 AM | Roger JeffsDirector, Chief Executive Officer | Sale | 3,300 | $40.00 | $132.0K | 1,491,934(I) | View → |
| Apr 15, 2026 | Apr 17 12:37 AM | Michael KasetaCFO and COO | Sale | 139,390 | $40.14 | $5.6M | 353,356(D) | View → |
| Apr 14, 2026 | Apr 17 12:37 AM | Michael KasetaCFO and COO | Sale | 3,000 | $40.00 | $120.0K | 405,775(D) | View → |
| Apr 16, 2026 | Apr 16 8:13 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $40.12 | $1.0M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Oct 14 12:05 AM | Russell SchundlerGeneral Counsel | Option Exercise | 10,167 | — | 57,680(D) | View → |
| Oct 9, 2026 | Oct 14 12:04 AM | Rajeev SaggarChief Medical Officer | Option Exercise | 8,016 | — | 40,376(D) | View → |
| Oct 9, 2026 | Oct 14 12:03 AM | Scott MoomawChief Commercial Officer | Option Exercise | 7,466 | — | 39,222(D) | View → |
| Oct 9, 2026 | Oct 14 12:02 AM | Sarah KreppChief Human Resource Officer | Option Exercise | 3,178 | — | 28,609(D) | View → |
| Oct 9, 2026 | Oct 14 12:00 AM | Michael KasetaCFO and COO | Option Exercise | 12,877 | — | 63,448(D) | View → |
| Oct 9, 2026 | Oct 13 11:59 PM | Roger JeffsDirector, Chief Executive Officer | Option Exercise | 28,166 | — | 128,996(D) | View → |
| Oct 9, 2026 | Oct 13 11:59 PM | Dana BoyleChief Accounting Officer | Option Exercise | 3,178 | — | 28,609(D) | View → |
| Oct 9, 2026 | Oct 13 11:58 PM | Jason AdairChief Business Officer | Option Exercise | 10,248 | — | 34,816(D) | View → |
| Sep 14, 2026 | Sep 15 8:30 PM | Raman SinghDirector | Option Exercise | 8,468 | $9.31 | 0(D) | View → |
| Sep 11, 2026 | Sep 15 8:30 PM | Raman SinghDirector | Option Exercise | 9,024 | $9.31 | 8,468(D) | View → |
| Aug 21, 2026 | Aug 25 8:30 PM | Jason AdairChief Business Officer | Option Exercise | 31,799 | $14.20 | 0(D) | View → |
| Aug 20, 2026 | Aug 21 8:30 PM | Katherine Rielly-GauvinDirector | Option Exercise | 18,393 | $2.59 | 0(D) | View → |
| Aug 19, 2026 | Aug 21 8:30 PM | Katherine Rielly-GauvinDirector | Option Exercise | 36,789 | $2.59 | 6,666(D) | View → |
| Aug 19, 2026 | Aug 19 10:21 PM | Rajeev SaggarChief Medical Officer | Option Exercise | 50,000 | $3.73 | 150,000(D) | View → |
| Jul 10, 2026 | Jul 15 12:11 AM | Sarah KreppChief Human Resource Officer | Option Exercise | 3,179 | — | 31,787(D) | View → |
| Jul 10, 2026 | Jul 15 12:08 AM | Michael KasetaCFO and COO | Option Exercise | 12,879 | — | 70,497(D) | View → |
| Jul 10, 2026 | Jul 15 12:07 AM | Roger JeffsDirector, Chief Executive Officer | Option Exercise | 28,167 | — | 143,329(D) | View → |
| Jul 10, 2026 | Jul 15 12:05 AM | Jason AdairChief Business Officer | Option Exercise | 10,251 | — | 38,684(D) | View → |
| Jul 10, 2026 | Jul 15 12:04 AM | Russell SchundlerGeneral Counsel | Option Exercise | 10,168 | — | 64,089(D) | View → |
| Jul 10, 2026 | Jul 15 12:02 AM | Rajeev SaggarChief Medical Officer | Option Exercise | 8,018 | — | 44,862(D) | View → |
Page 1 of 3
Next →